Control of vascular risk factors may lower the conversion rate.
Of individuals diagnosed with mild cognitive impairment, 10% to 15% annually go on to develop Alzheimer disease (AD). Vascular risk factors are associated with conversion to AD, but few studies have focused on whether treatment of these influences the conversion rate. Researchers in China examined this question in a 5-year follow-up study of 837 individuals with mild cognitive impairment. Progression was assessed with the Mini-Mental State Examination and the Activities of Daily Living scale.
By the final year, 298 subjects had converted to AD. Converters were slightly older at baseline than nonconverters (69 vs. 64), less educated, and more likely to be female (63% vs. 54%) or a blue-collar worker (59% vs. 51%) and had higher frequencies of…
Reviewing Author
DisclosuresRoyaltiesTextbook of Traumatic Brain Injury, 2nd and 3rd editions
Editorial BoardsUpToDate; Journal of Neuropsychiatry and Clinical Neuroscience
Leadership Positions in Professional SocietiesNorth American Brain Injury Association (Board Member); National Institute on Disability, Independent Living, and Rehabilitation Research (Chair of Data Monitoring Safety Board for study of donepezil on cognition after traumatic brain injury)
DisclosuresRoyaltiesTextbook of Traumatic Brain Injury, 2nd and 3rd editions
Editorial BoardsUpToDate; Journal of Neuropsychiatry and Clinical Neuroscience
Leadership Positions in Professional SocietiesNorth American Brain Injury Association (Board Member); National Institute on Disability, Independent Living, and Rehabilitation Research (Chair of Data Monitoring Safety Board for study of donepezil on cognition after traumatic brain injury)